A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/55 (2006.01) A61K 31/00 (2006.01) A61K 31/22 (2006.01) A61K 31/365 (2006.01) A61K 31/405 (2006.01) A61K 31/554 (2006.01)
Patent
CA 2473721
The use of an ileal bile acid transport (IBAT) inhibitor and the use of a combination of an IBAT inhibitor and an HMG CoA reductase inhibitor in the treatment of a warm-blooded animal, such as man, with hypercholesterolemia and/or other forms of dyslipidaemia wherein said hypercholesterolemia and dyslipidaemias are characterized by defects in lipoproteins or their receptors is described.
L'invention concerne l'utilisation d'un inhibiteur du transport de l'acide biliaire iléal (IBAT) et l'utilisation de l'association d'un inhibiteur du transport de l'acide biliaire iléal et d'un inhibiteur de la réductase CoA HMG pour traiter un animal à sang chaud, tel qu'un être humain, souffrant d'hypercholestérolémie et/ou d'autres formes de dyslipidémie, cette hypercholestérolémie et cette dyslipidémie étant caractérisées par des défauts des lipoprotéines ou de leurs récepteurs.
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Use of benzothiazepines having activity as inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of benzothiazepines having activity as inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of benzothiazepines having activity as inhibitors of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1631267